Who Owns SCNI?
Scinai Immunotherapeutics Ltd. — Institutional Ownership & 13F Holdings
$0.71
-0.00 (-0.01%)
Market Cap
$974K
Shares Outstanding
—
Institutional Holders
4
Total Inst. Value
$45K
% of Float Held
—
QoQ Holder Change
—
Institutional data as of Q1 2025
Top 10 Institutional Holders(Q1 2025)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | UBS Group AG | $40K | 14,932 |
| 2 | RHUMBLINE ADVISERS | $4K | 1,567 |
| 3 | CREDIT AGRICOLE S A | $113 | 42 |
| 4 | MORGAN STANLEY | $0 | 255 |
Related Stocks
Frequently Asked Questions
How many institutional investors hold SCNI?
As of Q1 2025, 4 institutional investors report holding SCNI (Scinai Immunotherapeutics Ltd.) in their 13F filings.
Which hedge fund owns the most SCNI?
The largest institutional holder of SCNI is UBS Group AG with $40K in shares.
Are institutions buying or selling SCNI?
This quarter, 4 institutions opened new positions in SCNI and 0 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.